Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
R&D Licensing
Filter     Order     Display # 
Date Item Title
10 Jun 2008 Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
08 Jun 2008 WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE(R) (CA9-SCAN)
05 Jun 2008 Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program
03 Jun 2008 Amira Pharmaceuticals achieves milestones in FLAP inhibitor program with GlaxoSmithKline
30 May 2008 Nuvo licenses topical pain product from Paladin
30 May 2008 Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
30 May 2008 Orion receives rights for incontinence drug Kentera(R) from Recordati
28 May 2008 4SC and ViroLogik conclude a licensing and cooperation agreement
27 May 2008 Inovio Biomedical Licenses Electroporation Delivery Technology to Leading U.S. Government Contractor, Advanced BioScience Laboratories, Inc.
13 May 2008 Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
12 May 2008 Theratechnologies and PDC Biotech GmbH sign license agreement for family of peptides for Preterm Labour and Primary Dysmenorrhea programs
07 May 2008 Par Pharmaceutical acquires Spectrum Pharmaceutical's interest in Sumatriptan Injection
02 May 2008 Biosimilar G-CSF: Cooperation on Three Continents.
02 May 2008 Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
01 May 2008 Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
25 Apr 2008 Astellas and CoMentis Sign Agreement to Collaborate on the Research, Development and Commercialization of Beta-Secretase Inhibitors
24 Apr 2008 Shire enhances its orphan drug pipeline with the acquisition of a new clinical candidate for Metachromatic Leukodystrophy
24 Apr 2008 Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and Commercialization Agreement for DX-88 Surgical Indications
21 Apr 2008 Actelion and Nippon Shinyaku enter into a license agreement on novel PAH compound
17 Apr 2008 Galapagos licenses clinical rheumatoid arthritis program
14 Apr 2008 Antisoma licenses rights to develop Betagenon's AMPK activators as cancer treatments
14 Apr 2008 Debiopharm and Airmid Sign Option and License Agreement
08 Apr 2008 Lorus Therapeutics announces exclusive multinational license agreement with zoticon bioventures for Virulizin(R)
08 Apr 2008 Bristol-Myers Squibb Selects Isis Drug Targeting PCSK9 as Development Candidate for Prevention and Treatment of Cardiovascular Disease
08 Apr 2008 Chelsea Therapeutics Gains Global Rights to I-3D Portfolio Targeting Autoimmune Disease and Transplant Rejection
07 Apr 2008 Targeted Genetics Acquires Rights to siRNA Development Program in Huntington's Disease From Sirna Therapeutics
31 Mar 2008 Sharing of Sabin-IPV Seed Virus by Japan Poliomyelitis Research Institute with Takeda and Grant of Right to Its Commercialization
29 Mar 2008 Actelion and Nippon Shinyaku to collaborate on novel PAH compound
25 Mar 2008 Ceragenix Enters into Agreement to License CSA-54 and other Ceragenin Compounds To Biopharmaceutical Company for HIV and STD Applications
20 Mar 2008 Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program
20 Mar 2008 Acambis extends Sanofi Pasteur licensing agreement on single-dose JE vaccine to India and Indian subcontinent
19 Mar 2008 Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
19 Mar 2008 Cenix BioScience Signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery
17 Mar 2008 Phylogica and Dynamic Microbials sign anti-bacterial deal
14 Mar 2008 Option to Develop Exelixis Compound Exercised By Genentech
13 Mar 2008 Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
12 Mar 2008 M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503
12 Mar 2008 Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
10 Mar 2008 Conclusion of Co-Development and Co-Marketing Agreement on Z-338 for Functional Dyspepsia in Japan with Astellas Pharma Inc.
10 Mar 2008 Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
10 Mar 2008 Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
10 Mar 2008 ZARS Pharma Announces Worldwide License Agreement with Galderma Pharma
06 Mar 2008 Oncolys BioPharma and Medigen Biotechnology Enters Strategic Alliance and License Agreement to Develop and Commercialize Telomelysin(R)(OBP-301) for a Potential New Treatment for Solid Tumors
05 Mar 2008 Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
04 Mar 2008 Endo Licenses U.S. Rights for Voltaren(R) Gel -- the First FDA-Approved Topical Treatment for Relief of Osteoarthritis Pain
03 Mar 2008 BioWa Announces Expansion of License Agreement With Genetech for BioWa's POTELLIGENT(R) Technology
29 Feb 2008 Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
28 Feb 2008 Karo Bio reacquires rights to SARM compounds from Radius
26 Feb 2008 Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
20 Feb 2008 Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-011 Program for Cancer-Related Bone Loss
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 101 - 150 of 814

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics